why choose us

Clinical Trials Search

Showing 18,630 of 132,963 result(s)
Safety and Efficacy of Faricimab in Patients With NPDR

Status: COMPLETED

Condition: Non-Proliferative Diabetic Retinopathy

Interventions: Faricimab is a humanized bispecific antibody binding to human Ang-2 and VEGF.
For Phase III studies, the Ro 686-7461 drug product is provided in

Date: 2022-11-04

Dapagliflozin Therapy In Cardiac Surgery

Status: COMPLETED

Condition: Diabetes Mellitus, Type 2

Interventions: The patients is required to receive dapagliflozin(10mg, q.d.) at least for 3 days until 24 hours before the surgery.
Then dapagliflozin will be d

Date: 2022-11-04

Study of Nab-Paclitaxel and Gemcitabine and Plus;Minus VCN-01 in Patients With Metastatic Pancreatic Cancer

Status: COMPLETED

Condition: Pancreatic Adenocarcinoma

Interventions: Nab-paclitaxel administered as an IV infusion at a rate of 125 mg;m2.
Nab-paclitaxel is administered on Day 1, Day 8 and Day 15 of each 28-d

Date: 2022-11-03

A Study in People With Advanced Cancer to Test How BI 907828 is Processed in the Body

Status: COMPLETED

Condition: Solid Tumors

Interventions: [¹?C]-BI 907828 mixed with BI 907828 (formulation 1)

Date: 2022-11-03

Furosemide Stress Test to Predict Successful Liberation From RRT

Status: COMPLETED

Condition: Acute Kidney Injury

Interventions: The FST corresponds to the intravenous single-dose administration of 1 mg;kg (1.5 mg;kg in previously exposed patients) of furosemide and th

Date: 2022-11-03

Kentucky Outreach Service Kiosk (KyOSK): Reducing HIV, HCV, and Overdose Risk

Status: Completed

Condition: Opioid-Related Disorders

Interventions: The intervention involves enhancing an existing staffed harm reduction program (syringe service program) located in a local health department with a K

Date: 2022-11-03

Adipose Dysfunction, Imaging, Physiology, and Outcomes With Sodium Glucose Cotransporter 2 Inhibitor (SGLT2i) for Sleep Apnea: The ADIPOSA Study

Status: NOT_YET_RECRUITING

Condition: Sleep Apnea

Interventions: 15mg once daily

Date: 2022-11-03

Enhancing PAP Adherence Among Spanish-speaking Hispanic Adults With OSA

Status: NOT_YET_RECRUITING

Condition: Obstructive Sleep Apnea

Interventions: A tele-management intervention that will deliver two-way messages to participants via a bot - a computer program that simulates human activity.
P

Date: 2022-11-03

Study of Nab-Paclitaxel and Gemcitabine and Plus;Minus VCN-01 in Patients With Metastatic Pancreatic Cancer

Status: Completed

Condition: Pancreatic Adenocarcinoma

Interventions: Nab-paclitaxel administered as a 30- to 40-minute IV infusion at a rate of 125 mg;m2.
Nab-paclitaxel is administered on Day 1, Day 8 and Day

Date: 2022-11-03